Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer

被引：0
|
作者：
Johnson, J. M. [1 ]
Bar Ad, V. [2 ]
Lorber, E. [1 ]
Luginbuhl, A. [3 ]
Curry, J. M. [3 ]
Cognetti, D. [3 ]
Keith, S. [4 ]
Axelrod, R. [1 ]
Zinner, R. [1 ]
Rodeck, U. [5 ]
Harshyne, L. A. [6 ]
Argiris, A. [7 ]
机构：
[1] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Otolaryngol, 1721 Pine St, Philadelphia, PA 19103 USA
[4] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[6] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA
[7] Hygeia Hosp, Med Oncol, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1126TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
    Johnson, Jennifer M.
    Vathiotis, Ioannis A.
    Harshyne, Larry A.
    Ali, Ayesha
    Bar Ad, Voichita
    Axelrod, Rita
    Lorber, Emily
    Curry, Joseph
    Cognetti, David M.
    Luginbuhl, Adam J.
    Tuluc, Madalina
    Keith, Scott
    Mahoney, My G.
    Argiris, Athanassios
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [2] Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
    Johnson, Jennifer Maria
    Bar Ad, Voichita
    Lorber, Emily
    Poller, Dawn
    Luginbuhl, Adam
    Curry, Joseph M.
    Cognetti, David M.
    Keith, Scott W.
    Axelrod, Rita Susan
    Zinner, Ralph
    Rodeck, Ulrich
    Harshyne, Larry
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Nivolumab Adjuvant in Combination with Postoperative Radiotherapy and as Maintenance in Patients with Intermediate Risk Locally Advanced Head and Neck Cancer - The NadiHN Trial
    Bauernfeind, Franz-Georg
    Schaefer, Henning
    Hautmann, Matthias
    Gauler, Thomas
    Mahlberg, Rolf
    Budach, Wilfried
    Tarnaskovics, Balint
    Baumann, Rene
    Eble, Michael
    Hasenkamp, Justin
    Koppelle, Adriane
    Reinacher-Schick, Anke
    Pigorsch, Steffi
    Lammert, Anne
    Meffert, Lisa
    Grosu, Anca-Ligia
    Hadizadeh, Dariusch
    Kristiansen, Glen
    Heimann, Martina
    Dietz, Andreas
    Brossart, Peter
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 95 - 95
  • [4] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [5] Use of chemotherapy in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
    Saber, RA
    Mohamad, SS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 510S - 510S
  • [6] Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
    Johnson, Jennifer Maria
    Bar Ad, Voichita
    Lorber, Emily
    Poller, Dawn
    Manukian, Gregor
    Luginbuhl, Adam
    Curry, Joseph M.
    Cognetti, David M.
    Keith, Scott W.
    Axelrod, Rita Susan
    Rodeck, Ulrich
    Harshyne, Larry
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
    Beckmann, GK
    Hoppe, F
    Pfreundner, L
    Flentje, MP
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (01): : 36 - 43
  • [8] Neoadjuvant Ipilimumab/Nivolumab combination in locally advanced or oligometastatic melanoma
    Ferrucci, Pier Francesco
    Lanfrancone, Luisa
    Mazzarella, Luca
    Nezi, Luigi
    Duso, Bruno Achutti
    Manzo, Teresa
    Lotti, Fiorenza
    Gandini, Sara
    Orsolini, Gianmarco
    Pennacchioli, Elisabetta
    Gnagnarella, Patrizia
    Fierro, Maria Teresa
    Senetta, Rebecca
    Riviello, Concetta
    Caliendo, Virginia
    Quaglino, Pietro
    Mazzarol, Giovanni
    Bonizzi, Giuseppina
    Cocorocchio, Emilia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (SUPPL 1)
  • [9] Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients
    Franzese, Ciro
    Fogliata, Antonella
    Franceschini, Davide
    Navarria, Pierina
    Cozzi, Luca
    Tomatis, Stefano
    De Virgilio, Armando
    Spriano, Giuseppe
    Scorsetti, Marta
    LARYNGOSCOPE, 2020, 130 (04): : E163 - E170
  • [10] Locally advanced head and neck cancer: chemoradiotherapy or acceleration of radiotherapy?
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2012, 99 (10) : 901 - 902
12345